Response to Baumgart review
- PMID: 20128003
- DOI: 10.1002/ibd.21201
Response to Baumgart review
Comment on
-
Veto on vedolizumab (MLN0002) for Crohn's disease.Inflamm Bowel Dis. 2010 Mar;16(3):537-8. doi: 10.1002/ibd.21078. Inflamm Bowel Dis. 2010. PMID: 19685452 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical